Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COG8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CCR6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TMEM8A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ENKD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | LRSAM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PHF10 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PLCB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | N4BP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | PRELID3A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |